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Measuring the impact of oesophagectomy
on physical functioning and physical
activity participation: a prospective study
E. M. Guinan1* , A. E. Bennett2, S. L. Doyle3, L. O’Neill4, J. Gannon4, G. Foley4, J. A. Elliott5, J. O’Sullivan6,
J. V. Reynolds5,6 and J. Hussey4

Abstract
Background: Oesophagectomy remains the only curative intervention for oesophageal cancer, with defined
nutritional and health-related quality of life (HR-QOL) consequences. It follows therefore that there is a significant
risk of decline in physical wellbeing with oesophagectomy however this has been inadequately quantified. This
study prospectively examines change in physical functioning and habitual physical activity participation, from presurgery through 6-months post-oesophagectomy.
Methods: Patients scheduled for oesophagectomy with curative intent were recruited. Key domains of physical
functioning including exercise tolerance (six-minute walk test (6MWT)) and muscle strength (hand-grip strength),
and habitual physical activity participation, including sedentary behaviour (accelerometry) were measured presurgery (T0) and repeated at 1-month (T1) and 6-months (T2) post-surgery. HR-QOL was measured using the
EORTC-QOL C30.
Results: Thirty-six participants were studied (mean age 62.4 (8.8) years, n = 26 male, n = 26 transthoracic
oesophagectomy). Mean 6MWT distance decreased significantly from T0 to T1 (p = 0.006) and returned to T0 levels
between T1 and T2 (p < 0.001). Percentage time spent sedentary increased throughout recovery (p < 0.001) and
remained significantly higher at T2 in comparison to T0 (p = 0.003). In contrast, percentage time spent engaged in
either light or moderate-to-vigorous intensity activity, all reduced significantly (p < 0.001 for both) and remained
significantly lower at T2 in comparison to T0 (p = 0.009 and p = 0.01 respectively). Patients reported deficits in
multiple domains of HR-QOL during recovery including global health status (p = 0.04), physical functioning (p <
0.001) and role functioning (p < 0.001). Role functioning remained a clinically important 33-points lower than preoperative values at T2.
Conclusion: Habitual physical activity participation remains significantly impaired at 6-months postoesophagectomy. Physical activity is a measurable and modifiable target for physical rehabilitation, which is closely
aligned with patient-reported deficits in role functioning. Rehabilitation aimed at optimising physical health in
oesophageal cancer survivorship is warranted.
Keywords: Physical functioning, Physical activity, Oesophageal cancer, Survivorship care, Health-related quality of life
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Background
Oesophagectomy is an exemplar model of a complex operation, with a relatively high postoperative risk of major
morbidity [1], and defined nutritional and health-related
quality of life (HR-QOL) implications [2, 3]. Oesophageal
cancer is the eighth most common cancer globally, with an
estimated 456,000 new cases in 2012 (3.2% of all cancers)
and the sixth most common cause of cancer mortality
(4.9% of all cancer deaths) [4]. Approximately 20% of patients diagnosed with oesophageal cancer undergo oesophagectomy with curative intent [5]. This complex procedure
involving upper laparotomy usually in combination with
thoracotomy and one lung anaesthesia, and is associated
with significant postoperative morbidity. Postoperative pulmonary complications (PPCs), which are among the most
serious postoperative morbidity, occur in 15–30% of patients post-oesophagectomy and are the primary cause of
postoperative mortality, contributing to 45.5–55% of postoesophagectomy deaths [6]. In the modern era, surgery is
preceded by chemotherapy or combination chemoradiotherapy for the majority of patients who present with locally
advanced disease [2]; an approach which has contributed to
5-year survival rates of up to 47% [7]. Accordingly, at a time
when overall survival is improving, there is a growing emphasis on the nutritional, physical and emotional wellbeing
of patients undergoing curative treatment for locally advanced disease [8].
Oesophageal cancer and its treatment, particularly
oesophagectomy, leads to significant anatomic and
physiologic alterations of the gastrointestinal tract and
thus the long-term nutritional implications of curative
treatment for oesophageal cancer are well documented
[9]. Up to 80% of patients are cachexic at presentation
[10], with recent data demonstrating that weight loss,
sarcopenia, malabsorption and altered gut hormone
function persist into survivorship [11–13]. Notwithstanding the considerable survival advantages of modern
multimodal treatment regimens when compared with
surgery alone [2, 7], chemotherapy and chemoradiotherapy can adversely impact body composition and muscle
strength [14], with emerging evidence linking loss of
skeletal muscle mass during neoadjuvant therapy with
chemotherapy toxicity and major postoperative complications [15].
It follows therefore that there is a significant risk of
decline in physical functioning resulting from both curative treatment for oesophageal cancer and poor nutritional status. Declines in cardiopulmonary fitness, a key
determinant of physical functioning [16], ability to engage in activities of daily living [17], and increased risk
of postoperative complications [18] are reported with
neoadjuvant chemo(radio)therapy [19–21], and associated with higher mortality risk at 1-year post oesophagectomy [21]. Physical inactivity is associated with
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increased postoperative risk following oesophagectomy
[22] and is a defined problem among cancer survivors
[23, 24], associated with HR-QOL [25] and, increasingly,
survival outcomes [26]. While an acute decline in physical fitness, muscle strength and HR-QOL is described
from pre-oesophagectomy to post-operative discharge
[17], prospective evaluations characterising the impact of
oesophagectomy on physical outcomes, particularly
long-term evaluations of physical functioning, are lacking [27]. Subjectively, patients report perceived deficits
in physical functioning domains of HR-QOL which persist into survivorship [28, 29]; however, the measured
impact of oesophagectomy on physical functioning is inadequately quantified. We have previously described deficits in cardiorespiratory fitness and moderate-tovigorous intensity physical activity participation in
oesophageal cancer survivors at up to two years postoperatively, in comparison to age- and gender-matched
controls [30], suggesting that curative treatment exerts a
profound and lasting impact on physical status.
With increasing emphasis on survivorship care in
oesophageal cancer, there is a recognised need to better
understand the physical consequences of oesophageal
cancer and its treatment in order to develop tailored rehabilitation programmes involving exercise and diet prescription to attenuate the impact of treatment on
physical functioning and optimise HR-QOL in recovery
[31]. Cancer survivorship models emphasise that exercise rehabilitation implemented early in the cancer continuum, particularly within the first 6-months
postoperatively, is likely to have the greatest impact on
HR-QOL [32]. This study therefore seeks to characterise
the impact of oesophagectomy on physical functioning
and habitual physical activity participation in early postoperative recovery and up to 6-months postoesophagectomy to inform targets and priorities for exercise rehabilitation during this period.

Methods
Study design

Patients with a diagnosis of oesophageal cancer and
scheduled for oesophagectomy were identified from the
upper gastrointestinal clinic at the Oesophageal and
Gastric Centre at St James’s Hospital (SJH), Dublin,
Ireland, a high-volume national centre. Ethical approval
was obtained from the SJH–Tallaght Hospital Joint Research Ethics Committee. Informed written consent was
obtained prior to study commencement. Using a prospective observational design, participants were recruited
pre-operatively and measurements were collected presurgery (T0), at 1-month post-surgery (T1) and at 6months post-surgery (T2). Visits were conducted in the
Wellcome Trust-HRB Clinical Research Facility at SJH.
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Clinical treatment

All participants were treated according to standardised
care pathways involving either multimodal therapy or
surgery only. Patients with locally advanced disease received either pre- and postoperative chemotherapy as
per the MAGIC regimen [33] or neoadjuvant chemoradiation as per the CROSS protocol [34]. Surgical resection was performed at least 6-weeks post neoadjuvant
therapy. The surgical approach involved either transthoracic en-bloc oesophagectomy (2-stage or 3-stage) or
transhiatial oesophagectomy following evaluation of patient demographics and comorbidities as previously described [35]. Postoperatively, patients were immediately
extubated and admitted to a monitored bed, normally
the high dependency unit (HDU). Patients were transferred to the ward on postoperative day (POD)3 or when
medically suitable. The institutional enhanced recovery
after surgery protocol included the following elements;
early enteral feeding via jejunostomy, early mobilisation
and airway clearance techniques from POD1, removal of
chest drains on POD2 and contrast study for anastomotic integrity on POD4. Postoperative analgesia was
managed using thoracic epidural analgesia. The jejunostomy remained in-situ for 4–6 weeks postoperatively and
supplemental overnight enteral nutrition was continued
on discharge for a planned duration of 4 weeks in all
participants [36]. Patients were reviewed at regular intervals postoperatively by the specialist dietetic service.
Clinical data

Demographic and clinicopathologic data was gathered
from medical charts and from the institutional upper
gastrointestinal cancer database. Postoperative data included in-hospital mortality, hospital and critical care
length of stay (LOS) and postoperative complications.
Measures of anthropometry

Weight (kg) was recorded using a calibrated Seca scale.
Height (cm) was measured barefoot using a Seca stadiometer. Body mass index (BMI) was calculated as weight
(kg)/height (m2). Mid-arm circumference (MAC) was
measured in cm at the halfway point between the olecranon process of the ulna and the acromion process of the
scapula. Waist circumference (cm) was measured at the
mid-point between the iliac crest and the 12th rib following gentle expiration. MAC and waist circumference
were taken in duplicate and averaged for data entry.
Bioimpedance analysis was used to determine body composition and was performed using the Seca mBCA 515
(Seca, Hamburg, Germany).
Measures of physical functioning

Functional exercise performance was measured using
the 6-min walk test (6MWT). Participants walked at
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their fastest pace for 6 min along a 30 m walkway with
the aim of achieving the furthest distance possible with
standardised verbal encouragement [37]. Isometric hand
grip strength (HGS) (kg) was measured using a handheld
digital dynamometer (Jamar). Measures were taken in
triplicate, bilaterally and the highest measure recorded.
Physical activity was measured using the ActiGraph
GT3X+ triaxial accelerometer (Actigraph Pensacola, FL).
The accelerometer was worn on the hip, secured with an
elastic belt, during waking hours for 7 days following all
study visits. Data were analysed using the Actilife software using standardised algorithms to analyse time in
physical activity domains and adherence to physical activity guidelines (150 min moderate-to-vigorous intensity
physical activity (MVPA)/week, accumulated in bouts
≥10 min [38]). The following cut-points were used to define activity domains: sedentary 0–99 counts per minute
(CPM), light 100–2019 CPM, moderate 2020–5998 and
vigorous ≥5999 [39]. A valid data was defined as one
with 10 h of data and at least four consecutive days were
required for analysis.
Measures of health-related quality of life

QOL was assessed using the European Organisation for
Research and Treatment of Cancer (EORTC) Core QOL
Questionnaire, the QLQ-C30 (version 3.0). This validated instrument assessed QOL in functional, symptom
and global domains. Scores for each question were calculated according to the EORTC QLQ-C30 manual and
linearly transformed into a 0–100 scale [40].
Sample-size considerations

This is an exploratory descriptive study, which considers
the impact of oesophagectomy on clinically important
outcomes using a patient-centred, multifaceted approach. Using previous literature to estimate an effect
size of 0.5 for the effect of treatment for oesophageal
cancer on physical status [14] a significance level of 0.05
and a power of 0.8, a sample size of 33 was calculated
for repeated measures. This sample estimate is consistent with other publications in this field [17].
Statistical analyses

SPSS version 22.0 was used for analyses. Variables were
tested for normality using the Shapiro-Wilks test. Normally distributed variables were summarised as mean
and standard deviation (SD). Non-normally distributed
data were summarised as median and interquartile range
(IQR). Categorical variables are presented as frequency
(percentage).
A mixed between-within subjects analysis of variance
(ANOVA) was conducted to assess the change in outcomes across three timepoints in consideration of the
impact of treatment regimen (CROSS, MAGIC or
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surgery only). Data was tested to ensure that the assumptions of homogeneity of variance (Levene’s test for
equal variances) and homogeneity of intercorrelations
(Box’s M statistic) were not violated. Multivariate statistics were interpreted. Interaction effects were examined
and reported where significant. Differences between the
groups were presented as partial eta squared (η2) effect
sizes. The strength of the differences was interpreted as
small (η2 < 0.01), medium (η2 = 0.01–0.06) or large (η2 =
0.06–0.138). Post-hoc pairwise comparison for comparison of main effects were examined using Bonferroni
analysis. A Friedman test was used to examine changes
in non-parametric outcomes over the three timepoints.
Associations between measures of anthropometry and
measures of functional performance were assessed using
Pearson Product Moment Correlation Coefficients. Statistical significance was taken at p < 0.05.

Results
Between January 2014 and October 2016, 52 patients were
recruited and tested pre-surgery, of whom 43 returned for
repeat measures 1-month post-surgery and 36 returned at
6-months post-surgery. The mean time between a presurgery assessment and a 1-month post-surgery assessment was 66 (21) days. The mean time between 1-month
and 6-months post-surgery assessments was 157 (42) days.
Reasons for not completing follow-up measurements
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were: disease progression (n = 6); prolonged postoperative
morbidity (n = 3); participant death (n = 2) and participant
drop-out (n = 5) (Fig. 1). Demographic characteristics are
presented in Table 1. Demographic characteristics of the
final sample were comparable to those lost to follow-up.
Anthropometry

Body weight, BMI, fat mass, body fat percentage, fat free
mass (FFM), skeletal muscle mass, waist circumference
and MAC all reduced significantly over the study period
(Table 2). Pre-operatively, participants had a mean body
weight of 81.9 (16.4) kg and a mean BMI of 27.8 (4.3 kg/
m2. Male participants had a pre-operative waist circumference of 98.6 (12.3) cm and female participants had a
mean waist circumference of 91.38 (9.8) cm. Percentage
weight loss from pre-surgery to 1-month (− 6.2 (4.3) %)
and to 6-months (− 8.9 (7.4) %) post-surgery was clinically significant. There was no impact of treatment approach on weight (p = 0.356, η2 = 0.069), BMI (p = 0.963,
η2 = 0.003), fat mass (p = 0.0.78, η2 = 0.225), body fat
percentage (p = 0.375, η2 = 0.082), skeletal muscle mass
(p = 0.102, η2 = 0.188), waist circumference (p = 0.306,
η2 = 0.102) or MAC (p = 0.399, η2 = 0.088).
Physical functioning

Pre-operatively, male participants walked a mean distance of 513.7 (73.6)m and female participants walked a

Fig. 1 Participant Recruitment and Retention. Flow of participants through the study
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Table 1 Demographic Details
Characteristic

All Participants (n = 52)

Participants included in the Final Analysis (n = 36)

p-value

Age (SD) (years)

62.48 ± 9.03

62.39 (8.82)

0.91

n

%

Male

39

75

26

72

Female

13

25

10

28

Gender
0.73

Smoking Status
Never

21

40

12

33

Stopped > 8 weeks preoperative

28

54

22

61

Stopped < 8 weeks preoperative

1

2

1

3

Current smoker

2

4

1

3

Adenocarcinoma

38

73

25

69

Squamous Cell Carcinoma

14

27

11

31

N/A

Histological Subtype
0.51

Neo-adjuvant therapy protocol
CROSS

28

54

15

42

MAGIC

12

23

12

33

No neoadjuvant therapy

12

23

9

25

N/A

ASA Score
1

4

8

4

11

2

35

67

24

67

3

13

25

8

22

N/A

Surgical Approach
Transthoracic

40

77

26

72

Transhiatial

12

23

10

28

0.30

Postoperative Recovery
Hospital Length of Stay (median (IQR)

13.5 (9)

13.0 (7)

0.86

Critical Care Length of Stay (median (IQR)

3.0 (1.75)

Postoperative Complications

31

60

19

53

0.72

In-hospital Postoperative Mortality

1

2

0

0

0.29

3.0 (1.0)

0.07

Data is displayed as mean (standard deviation (SD)) for normally distributed data and as median (interquartile range (IQR) for non-normally distributed data.
Categorical data is presented as frequency (percentage). P-value comparing all participants recruited to those included in the final analysis. N/A = chi squared
test invalid

Table 2 Change in Measures of Anthropometry Post Oesophagectomy
Pre-Surgery (T0) 1-month Post-Surgery (T1) 6-Months Post-Surgery (T2) P-value Multivariate Partial Eta Squared
Anthropometry
Weight (kg)

81.9 (16.4)
2

76.9(14.8)*

73.8 (13.2)** §

Body Mass Index (kg/m )

27.8 (4.3)

26.3 (3.9)*

25.3 (3.7)**

§

Fat Mass (kg)

27.2 (8.7)

25.5 (8.3)*

22.0 (8.6)**

§

§

Body Fat Percentage (%)

33.6 (7.8)

33.6 (8.2)

30.2 (9.1)

Fat Free Mass (kg)

54.5 (9.9)

51.3 (8.8)*

50.7 (11.1)
§

< 0.001 0.67
< 0.001 0.66
< 0.001 0.59
< 0.001 0.55

§

< 0.001 0.48

Skeletal Muscle Mass (kg)

27.0 (5.4)

24.6 (4.9)*

24.6 (4.8)

Waist Circumference (cm)

97.17 (14.1)

94.5 (11.9)

91.6 (11.2) §

0.002

0.42

28.4 (2.9)*

28.9 (2.7)

0.02

0.31

Mid-Arm Circumference (cm) 29.8 (3.4)

< 0.001 0.63

Data is presented as mean (standard deviation) for all variables. P-value for one-way repeated measures ANOVA. *difference between T0 and T1 p < 0.05; **
difference between T1 and T2 p < 0.05; §difference between T0 and T2 p < 0.05
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mean distance of 477.6 (76.0)m during the 6MWT. Significant changes in 6MWT distance were observed over
the study period (p < 0.001, η2 = 0.51) (Table 3). Mean
6MWT distance decreased significantly from presurgery (502.6 (76.7)m) to 1-month post-surgery (463.5
(98.4)m) (mean change − 39.1 (95%CI − 68.3 to − 9.9)m,
p = 0.006), and then increased from 1-month postsurgery to 6-months post-surgery (507.8 (87.8)m) (mean
change 44.3 (95%CI 23.0 to 65.5)m, p < 0.001) (Fig. 2a).
There was no difference between the distance walked
pre-surgery and at 6 months post-surgery (p = 1.00).
There was no impact of treatment approach on 6MWT
distance (p = 0.639, η2 = 0.033). Distance walked during
the 6MWT did not correlate with any measure of body
composition at any timepoint.
Preoperatively, mean HGS was 38.4 (8.0) kg in
males and 23.6 (4.8) kg in females. Mean HGS did
not change over time from pre-surgery (35.5 (9.9) kg);
neither to 1-month post-surgery (33.9 (9.9) kg) nor to
6-months post-surgery (35.8 (10.9) kg) (p = 0.91, η2 =
0.15) (Table 3). There was no impact of treatment approach on HGS (p = 0.706, η2 = 0.025). HGS correlated positively and strongly with skeletal muscle
mass at T0 (r = 0.78, p < 0.001), T1 (r = 0.73, p <
0.001) and T3 (r = 0.68, p < 0.001).

On post-hoc analysis, sedentary behaviour increased
from pre-surgery (7.2 (1.6) hours/day) to 1-month postsurgery (8.7 (1.7) hours per day) (mean change (1.5
(0.39–2.7 h per day), p < 0.05) and remained elevated at
six-months post-surgery (8.46 (1.7) hours/day) (Fig. 2b).
At 6-months post-surgery, sedentary behaviour was significantly higher than pre-operative levels (mean difference 1.3 (0.4–2.2 h/day), p = 0.05). Sedentary behaviour
did not correlate with skeletal muscle mass at any
timepoint.
In contrast, light intensity activity decreased from presurgery (4.1 (1.5) hours/day) to 1-month post-surgery
(2.3 (0.9) hours per day (mean change − 1.8 (95%CI 2.5
to − 1.1) (p < 0.05) and increased from 1-month postsurgery to six months post-surgery (3.5 (1.4) hours/day
(mean change 1.2 (95%CI 0.5 to 1.9) hours/day, p < 0.05)
(Fig. 2c). Minutes spent engaging in light intensity activity did not correlate with skeletal muscle mass at any
timepoint.
Similarly, daily minutes spent engaging in MVPA, decreased from a median of 11.5 (31.6) minutes/day presurgery to 4.7 (12.9) minutes/day at 1-month postsurgery (p < 0.001), and increased from 1-month postoperative to 6-months postoperatively (12.5 (24.6) minutes/
day (p = 0.001) (Fig. 2c). At 6-months post-surgery, daily
minutes spent engaging in MVPA was significantly lower
than preoperative levels (p = 0.01).

Habitual physical activity

In the week before surgery, participants spent 7.2 (1.6)
hours/day sedentary, 4.1 (1.5) hours/day engaged in light
intensity activity and a median of 11.5 (31.6) minutes/
day engaging in moderate-to-vigorous intensity activity.
There were significant effects for time for sedentary behaviour (p < 0.002, η2 = 0.46), light intensity activity (p <
0.001, η2 = 0.69), and daily MVPA (p < 0.001) (Table 3).
There was no impact of treatment approach on either
sedentary behaviour (p = 0.766, η2 = 0.028) or light intensity activity participation (p = 0.694, η2 = 0.038).

Health-related quality of life

Health-related quality of life scores are detailed in
Table 4. There were significant changes over time in
multiple domains of quality of life on the QLQ-C30 including global health status (p = 0.04), physical functioning (p < 0.001), role functioning (p < 0.001), fatigue (p <
0.001), pain (p < 0.001), dyspnoea (p < 0.001), appetite
loss (p = 0.002) and diarrhoea (p = 0.004). Clinically important (> 10-point) change in physical function and role
function was reported from pre-surgery to 1-month

Table 3 Functional Performance and Physical Activity Post Oesophagectomy
Pre-Surgery (T0)

1-month
Post-Surgery (T1)

6-Months
Post-Surgery (T2)

P-value

Multivariate Partial
Eta Squared

Six Minute Walk Test Distance (m)

502.6 (76.7)

463.5 (98.4)*

507.8 (87.8)**

< 0.001

0.51

Hand Grip Strength (kg)

35.5 (9.9)

33.9 (9.9)

35.8 (10.9)

0.15

0.15

Sedentary behaviour (hours/day)

7.2 (1.6)

8.7 (1.7))*

8.5 (1.7)§

0.002

0.46

Light intensity activity (hours/day

4.1 (1.5)

2.3 (0.9)*

3.5 (1.4)**

< 0.001

0.69

Moderate to vigorous intensity activity (minutes/day)

11.5 (31.6)

4.7 (12.9)*

12.5 (24.6)** §

< 0.001

N/A

Adherence to physical activity guidelines

n = 11

n=2

n=6

N/A

N/A

Functional Performance

Physical Activity

Data is presented as mean (standard deviation) for all continuous variables with the exception of moderate to vigorous intensity activity which is presented as
median (interquartile range). P-value for one-way repeated measures ANOVA and Friedman’s Test. *mean difference between T0 and T1 p < 0.05; ** difference
between T1 and T2 p < 0.05; §difference between T0 and T2 p < 0.05
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Fig. 2 Functional Exercise Tolerance and Physical Activity Levels Pre-Surgery and at 1-Month and 6-Months Post-Surgery. Box-plots depicting
distance walked during the six-minute walk test distance (Fig. 1a), percentage walking hours spent sedentary (Fig. 1b) and in light intensity
activity (Fig. 1c) and minutes per day spent in moderate-to-vigorous intensity activity (Fig. 1d) at each timepoint. All participants experienced
significant acute decreases in walk distance and activity levels from pre-surgery to 1-month post-surgery which improved again to 6-months
post-surgery, however all domains of physical activity, including sedentary behaviour, remained impaired at 6-months post-surgery in comparison
to pre-surgery values

post-surgery. Role functioning remained impaired (33points lower) at 6-months post-surgery in comparison
with pre-operative values.

Discussion
This study provides a novel prospective evaluation of measured and perceived change in physical functioning following oesophagectomy. It demonstrates that habitual physical
activity participation and perceived role functioning remain
significantly impaired at 6-months post-surgery, despite exercise capacity recovering to preoperative levels. Consistent
with previous reports, symptom scores worsened postoperatively [41] and percentage weight loss was clinically significant at 6-months [13]. This significant and clinically relevant
pattern of deterioration highlights the challenges of

transitioning from active treatment to survivorship postoesophagectomy and adjusting to the ‘new normal’ after
cancer.
The significant short-term and long-term impairments
in global HR-QOL, and specifically in physical functioning and symptom burden, that arise following oesophagectomy are well-reported [3, 29, 41–43]. Consistent
with the pattern of deterioration in HR-QOL reported
by others [41, 42], we observed the largest postoperative
impact in the physical functioning domain, specifically
in the physical function and role function scales, of the
EORTC QOQ-C30. While both scales had improved by
6-months post-surgery, role function remained a clinically relevant 33-points lower in comparison with preoperative values. Clinically important deteriorations in
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Table 4 Health Related Quality of Life Post Oesophagectomy
Pre-Surgery (T0)

1-month Post-Surgery (T1)

6-Months Post-Surgery (T2)

P-value

66.7 (16.7)

58.3 (16.7)*

66.7 (16.7)

0.04

Physical Function

93.3 (20.0)

73.3 (40.0)*

86.7 (40.0)**

< 0.001

Role Function

100.0 (33.3)

50.0 (33.3)*

66.7 (33.3)**

< 0.001

Emotional Function

91.7 (33.3)

91.7 (25.0)

91.7 (16.7)

0.337

Cognitive Function

83.3 (33.3)

83.3 (33.3)

100 (16.7)

0.545

Social Function

66.7 (33.3)

66.7 (50.0)

66.7 (50.0)

0.401

Fatigue

22.2 (22.2)

33.3 (22.2)*

33.3 (22.2)**

< 0.001

Nausea/Vomiting

0.0 (16.7)

16.7 (33.3)*

0.0 (16.7)

0.03

Pain

0.0 (16.7)

33.3 (16.7)*

0.0 (33.3)

< 0.001

Dyspnoea

0.0 (0.0)

33.3 (0.0)*

33.3 (33.3)

< 0.001

Insomnia

33.3 (66.7)

33.3 (41.7)

33.3 (33.3)

0.284

Appetite Loss

0.0 (33.3)

33.3 (33.3)*

0.0 (33.3)

0.002

Constipation

0.0 (0.0)

0.0 (33.3)

0.0 (0.0)

0.497

Diarrhoea

0.0 (0.0)

33.3 (33.3)*

0.0 (33.3)

0.004

Financial Difficulties

33.3 (66.7)

33.3 (66.7)

33.3 (66.7)

0.232

Global Health Status
Functional Scales

Symptom Scales

Data is presented as median (inter-quartile range) for all variables. P-value for Friedman’s Test
*difference between T0 and T1 p < 0.05; ** difference between T1 and T2 p < 0.05

physical functioning are reported with all curative interventions for oesophageal cancer, including neoadjuvant
therapy, minimally invasive surgery and open surgical resection [29]. Importantly however, despite improvements
in the majority of HR-QOL domains over time, patientperceived physical functioning remains impaired at 1year [41], 2-years [44] and up to 3-years post oesophagectomy [43]. Uniquely, we demonstrate that this profound patient-perceived deterioration in physical health
is matched by clinically relevant changes in habitual activity participation.
Functional decline associated with cancer treatment is
typically examined using validated, objective measures of
physical functioning [16]. Using this approach, we observed an acute deterioration in physical activity participation, as measured by accelerometry, at 1-month postoesophagectomy, with physical activity levels and sedentary behaviour remaining impaired at 6-months. Consistent with this, we have previously reported that
moderate-to-vigorous intensity activity participation is
significantly lower at 2-years post-oesophagectomy in
comparison with age- and gender-matched controls [30].
Importantly, accelerometry captures habitual activity
participation during waking hours and therefore, engagement in activities of daily living, a construct that is wellaligned with the role functioning domain of the EORTC
QLQ-C30 [45], which was were perceived by participants to remain considerably impaired in survivorship.
Role functioning considers an individual’s ability to

engage in activities that are typical for their age and social setting [45]. In patients with cancer, physical activity
levels are known to reduce at cancer diagnosis and rarely
return to baseline levels following treatment completion
[24]. Compared to those who are inactive or suboptimally active, cancer survivors who exercise to recommended levels consistently report higher HR-QOL
scores, particularly in physical and role functioning domains [25], hypothesised to be driven by the positive effects of physical fitness on mental wellbeing and social
engagement [46], making physical activity an important
and influential target in survivorship care.
Cardiopulmonary fitness, the primary measure of physical functioning [16], is impaired by the iterative attritional
impact of multimodal treatment regimens in oesophageal
cancer [27]. We observed a large, clinically important reduction (− 39.10 (95%CI − 68.28 to − 9.92) m) in 6MWT
distance at 1-month post-oesophagectomy, consistent
with the decline previously reported in a Japanese cohort
from pre-surgery (563.3 (73.2) m) to pre-hospital discharge (485.3 (85.6) m) [17]. In colorectal resection,
6MWT distance at 4-weeks post-surgery is discriminative
of older age, poorer physical status, open resection and
occurrence of postoperative complications, and therefore
is a valuable indicator of early physical recovery [47].
While the 6MWT provides a valid measure of functional
exercise status in patients with cancer [48], reliability and
reproducibility data is lacking [16], and walking distances
correlate poorly with cardiopulmonary fitness in
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comparison with incremental walking protocols [49]. In
contrast to our observation that 6MWT distance returned
to preoperative values at 6-months postoperatively, suggesting an element of natural recovery in this cohort, a
study in a Japanese cohort, utilising the highly sensitive
cardiopulmonary exercise test, reported a reduction in exercise capacity from 1186.6 (300.30) ml/min preoesophagectomy to 916.1 (238.6) ml/min 3-months postoperatively (p < 0.0001) following open resection [50]. Furthermore, we previously reported significantly lower
walking distance in disease-free patients up to 2-years
post-oesophagectomy (558.33 (146.43)m) in comparison
with age- and gender-matched controls (773.48 (114.00)
m) using a progressive, incremental walking protocol [30].
Therefore, it is likely that cardiopulmonary fitness remains
impaired in oesophageal cancer survivorship; however further prospective evaluations using sensitive measures of
fitness are required.
The nutritional challenge of recovery postoesophagectomy is well-documented. Consistent with previous reports, in this cohort weight loss remained significant at 6-months [13] and symptom burden was
considerable in early post-operative recovery. While HGS,
a reliable indicator of whole-body muscle strength and nutritional status [51], remained stable over the study period,
we have previously reported significant deficits in grip
strength with loss of lean body mass during neo-adjuvant
therapy [14]. Furthermore, sarcopenia remains prevalent
in survivorship with 35% of patients sarcopenic at 1-year
post-oesophagectomy [13]. This complex interplay between nutritional insufficiency and physical deterioration
makes survivorship rehabilitation particularly challenging.
We recently designed, implemented and evaluated the Rehabilitation Strategies Following Oesophagogastric Cancer
(ReStOre) programme, a rehabilitation programme for
oesophagogastric survivorship comprising exercise training, individualised dietary counselling and multidisciplinary education, with a strong focus on self-management
[52–54], leading to clinically important improvements in
cardiopulmonary fitness [52], inflammatory status [53],
and multiple domains of HR-QOL [54]. The ReStOre
programme, the first exemplar in oesophagogastric cancer
rehabilitation, included participants up to 5-years postsurgery, however rehabilitative measures implemented
earlier in survivorship, particularly within the first 6months, are likely to have greatest effect [32] and address
the issues identified by this work. Consistent with
established clinical rehabilitation models, cancer rehabilitation commencing from diagnosis and continuing through the treatment trajectory, may have a key
role in attenuating the impact of multiple attritional
oncologic treatments, optimising patient condition for
surgical intervention and supporting patients through
recovery and into survivorship [8, 31].
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This work has some limitations which are acknowledged. Firstly, participant retention was challenging with
69% of those initially recruited (n = 52) available for
evaluation at 6-months (n = 36). This is an inevitable
challenge of prospective data collection in a cohort
undergoing complex surgical and medical interventions.
Reasons for attrition are reported and were largely attributed to disease progression and protracted postoperative morbidity. Importantly, those included in the final
analyses had comparable baseline characteristics to those
lost to follow-up. Nonetheless, the final study cohort
represent those who are recovering relatively well at 6
months post-surgery and therefore generalisability is
limited. The sample size is comparable to other published work in this field [17, 30, 50]. The use of objective
measures of physical functioning is a considerable
strength of this work. By employing these methods, multiple measurable and modifiable targets for physical rehabilitation were identified which were well-aligned with
patient-reported survivorship issues.

Conclusions
These results add to the growing evidence that improvements in oncological outcomes in oesophageal cancer
have led to a newly emergent cohort of cancer survivors
with considerable physical and nutritional concerns. Importantly, results identify deficits in both perceived role
functioning and measured activity participation in recovery, suggesting that patients experience considerable
challenges adjusting to the ‘new normal’ in survivorship.
Multidisciplinary rehabilitation with a strong focus on
self-management and overcoming barriers to habitual
activity participation is warranted.
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